Chemotherapy in epithelial ovarian cancer

被引：79
作者：
Pignata, Sandro [1 ]
Cannella, Lucia [1 ]
Leopardo, Davide [1 ]
Pisano, Carmela [1 ]
Bruni, Giovanni Salvatore [1 ]
Facchini, Gaetano [1 ]
机构：
[1] Natl Canc Inst Naples, Dept Urol & Gynecol, Div Med Oncol, I-80131 Naples, Italy
来源：
CANCER LETTERS | 2011年 / 303卷 / 02期
关键词：
Ovarian cancer; Chemotherapy; PEGYLATED LIPOSOMAL DOXORUBICIN; PHASE-III TRIAL; PACLITAXEL-RESISTANT OVARIAN; GYNECOLOGIC-ONCOLOGY-GROUP; INTRAPERITONEAL CISPLATIN; INTERGROUP TRIAL; RANDOMIZED-TRIAL; INTRAVENOUS CHEMOTHERAPY; DOCETAXEL-CARBOPLATIN; 1ST-LINE TREATMENT;
D O I：
10.1016/j.canlet.2011.01.026
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Epithelial ovarian cancer is the most common type of ovarian cancer; usually occurs in women older than 50 years, and because 75% of cases are diagnosed at stage III or IV it is associated with a poor prognosis. Treatment of ovarian cancer is based on the integration of surgery and chemotherapy. Chemotherapy plays a major role both in the adjuvant treatment and in the care of patients with advanced disease. Several active drugs have been introduced in the treatment of ovarian cancer in the last decades and novel targets and agents are under evaluation. (C) 2011 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码：73 / 83
页数：11
相关论文
共 50 条
[41]   Intraperitoneal and Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Ovarian Cancer [J].
Wang, Joyce Y. ;
Gross, Maya ;
Urban, Renata R. ;
Jorge, Soledad .
CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2024, :313-329
[42]   Patterns of chemotherapy treatment for women with invasive epithelial ovarian cancer - A population-based study [J].
Jordan, S. ;
Steer, C. ;
DeFazio, A. ;
Quinn, M. ;
Obermair, A. ;
Friedlander, M. ;
Francis, J. ;
O'Brien, S. ;
Goss, G. ;
Wyld, D. ;
Webb, P. .
GYNECOLOGIC ONCOLOGY, 2013, 129 (02) :310-317
[43]   A network meta-analysis of eight chemotherapy regimens for treatment of advanced ovarian cancer [J].
Jiang, Xi-Ping ;
Rui, Xiao-Hui ;
Guo, Cai-Xia ;
Huang, Ya-Qing ;
Li, Qin ;
Xu, Yun .
ONCOTARGET, 2017, 8 (12) :19125-19136
[44]   Maintenance therapy in epithelial ovarian cancer: from chemotherapy to targeted agents [J].
Falci, Cristina ;
Dieci, Maria Vittoria ;
Guarneri, Valentina ;
Solda, Caterina ;
Bria, Emilio ;
Tortora, Giampaolo ;
Conte, Pierfranco .
EXPERT REVIEW OF ANTICANCER THERAPY, 2014, 14 (09) :1041-1050
[45]   Analysis of clinical effects of neoadjuvant chemotherapy in advanced epithelial ovarian cancer [J].
Jiang, Yanhua ;
He, Wenfeng ;
Yang, Heng ;
Su, Zhenwen ;
Sun, Lixin .
JOURNAL OF BUON, 2018, 23 (03) :758-762
[46]   Olaparib for the treatment of epithelial ovarian cancer [J].
McLachlan, Jennifer ;
Banerjee, Susana .
EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (07) :995-1003
[47]   Surgery for Recurrent Epithelial Ovarian Cancer [J].
Fotopoulou, Christina ;
Eriksson, Ane Gerda ;
Yagel, Itai ;
Chang, Suk-Joon ;
Lim, Myong Cheol .
CURRENT ONCOLOGY REPORTS, 2024, 26 (01) :46-54
[48]   Chemotherapy for advanced epithelial ovarian carcinoma [J].
Kalil, NGN ;
McGuire, WP .
BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY, 2002, 16 (04) :553-+
[49]   Treatment of recurrent epithelial ovarian cancer [J].
Pignata, Sandro ;
Pisano, Carmela ;
Di Napoli, Marilena ;
Cecere, Sabrina Chiara ;
Tambaro, Rosa ;
Attademo, Laura .
CANCER, 2019, 125 :4609-4615
[50]   Intraperitoneal chemotherapy in advanced epithelial ovarian cancer: a survey [J].
Grosso, Giuseppe ;
Rossetti, Diego ;
Coccolini, Federico ;
Bogani, Giorgio ;
Ansaloni, Luca ;
Frigerio, Luigi .
ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2014, 290 (03) :425-434
12345